Gilead to begin human trials for the inhaled version of coronavirus drug remdesivir

Gilead Sciences will begin human trials for an inhaled version of its antiviral drug remdesivir in August, the biotech company said.

from Health and Science https://ift.tt/2YXu43R
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH